Summary
- Current Price
- As of today, APGE price is $66.04, down -3.59% on
- Current Price All-Time High
- APGE price is currently -21.90% below its historical high of $84.56 set on
- Market Cap
- APGE current market cap is $5B, up +92.40% over the past 365 days
- PE Ratio
- APGE PE ratio is unknown
- Revenue
- APGE current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for APGE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Apogee Therapeutics, Inc. |
| Ticker | NASDAQ: APGE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | apogeetherapeutics.com |
| Employees | 196 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $66.04 | |
| Price, 1D Change | -3.59% | |
| $5B | ||
| - | ||
| - | ||
| 1.23 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.22 | ||
| EPS, 1Y Change | -27.74% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.22 | ||
| EPS Estimate | N/A | -$4.86 |
| EPS Est. Change | N/A | -15.35% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $66.04 | |
| Price Target | - | $100.00 |
| Price Tgt. Change | - | +51.42% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.09 | -$3.30 | -6.66% | |
| -$4.20 | -$4.22 | -0.39% | |
| -$4.86 | N/A | -15.35% | |
| -$5.47 | N/A | -29.80% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $3.85M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $66.04 | |
| $55.53 | ||
| SMA 200 vs Price | -15.91% | |
| $71.39 | ||
| SMA 50 vs Price | +8.10% | |
| 1.23 | ||
| $3.91 | ||
| 39.74 | ||
| 37.00% | ||
| 59.53% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.22 | ||
| -$1.42M | ||
| - | ||
| -$285.60M | ||
| - | ||
| -$255.84M | ||
| - | ||
| -$284.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 26.57 | ||
| 26.57 | ||
| - | ||
| - | ||
| 80.48 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.99 | ||
| -13.34 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $903.88M | ||
| $730.19M | ||
| $937.13M | ||
| $741.36M | ||
| $33.25M | ||
| $27.91M | ||
| $8.85M | ||
| $3.50M | ||
| $1.22M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $255.84M | ||
| $284.18M | ||
| $1.42M | ||
| $0.00 | ||
| $1.42M | ||
| $0.00 | ||
| $278.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$227.45M | ||
| -$179.57M | ||
| $396.49M | ||
| $5.15M | ||
| -$232.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | ||
| BTIG | → | |
| Wedbush | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Wolfe Research | ||
| BTIG | → | |
| BTIG | → | |
| Stephens & Co. | ||
| Deutsche Bank |
Analyst sentiment
Institutional ownership
Screeners with APGE
FAQ
What is the ticker symbol for Apogee Therapeutics, Inc.?
The ticker symbol for Apogee Therapeutics, Inc. is NASDAQ:APGE
Does Apogee Therapeutics, Inc. pay dividends?
No, Apogee Therapeutics, Inc. does not pay dividends
What sector is Apogee Therapeutics, Inc. in?
Apogee Therapeutics, Inc. is in the Healthcare sector
What industry is Apogee Therapeutics, Inc. in?
Apogee Therapeutics, Inc. is in the Biotechnology industry
What country is Apogee Therapeutics, Inc. based in?
Apogee Therapeutics, Inc. is headquartered in United States
When did Apogee Therapeutics, Inc. go public?
Apogee Therapeutics, Inc. initial public offering (IPO) was on July 14, 2023
Is Apogee Therapeutics, Inc. in the S&P 500?
No, Apogee Therapeutics, Inc. is not included in the S&P 500 index
Is Apogee Therapeutics, Inc. in the NASDAQ 100?
No, Apogee Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Apogee Therapeutics, Inc. in the Dow Jones?
No, Apogee Therapeutics, Inc. is not included in the Dow Jones index
When was Apogee Therapeutics, Inc. last earnings report?
Apogee Therapeutics, Inc.'s most recent earnings report was on March 2, 2026
When does Apogee Therapeutics, Inc. report earnings?
The next expected earnings date for Apogee Therapeutics, Inc. is May 11, 2026
Data Sources & References
- APGE Official Website www.apogeetherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1974640/000197464026000002/0001974640-26-000002-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1974640/000197464026000002/0001974640-26-000002-index.htm
- APGE Profile on Yahoo Finance finance.yahoo.com/quote/APGE
- APGE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apge